- Home
- CVEO vs RCKT Comparison
CVEO vs RCKT Comparison
Compare CVEO & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVEO
- RCKT
- Stock Information
- Founded
- CVEO 1977
- RCKT 1999
- Country
- CVEO United States
- RCKT United States
- Employees
- CVEO N/A
- RCKT N/A
- Industry
- CVEO Hotels/Resorts
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- CVEO Consumer Discretionary
- RCKT Health Care
- Exchange
- CVEO Nasdaq
- RCKT Nasdaq
- Market Cap
- CVEO 281.2M
- RCKT 326.4M
- IPO Year
- CVEO N/A
- RCKT N/A
- Fundamental
- Price
- CVEO $22.57
- RCKT $2.70
- Analyst Decision
- CVEO Strong Buy
- RCKT Buy
- Analyst Count
- CVEO 1
- RCKT 13
- Target Price
- CVEO $27.00
- RCKT $18.50
- AVG Volume (30 Days)
- CVEO 90.4K
- RCKT 8.1M
- Earning Date
- CVEO 07-29-2025
- RCKT 08-04-2025
- Dividend Yield
- CVEO 4.41%
- RCKT N/A
- EPS Growth
- CVEO N/A
- RCKT N/A
- EPS
- CVEO N/A
- RCKT N/A
- Revenue
- CVEO $660,046,000.00
- RCKT N/A
- Revenue This Year
- CVEO N/A
- RCKT N/A
- Revenue Next Year
- CVEO $4.45
- RCKT N/A
- P/E Ratio
- CVEO N/A
- RCKT N/A
- Revenue Growth
- CVEO N/A
- RCKT N/A
- 52 Week Low
- CVEO $18.01
- RCKT $2.19
- 52 Week High
- CVEO $28.92
- RCKT $26.98
- Technical
- Relative Strength Index (RSI)
- CVEO 59.44
- RCKT 32.09
- Support Level
- CVEO $22.12
- RCKT $2.66
- Resistance Level
- CVEO $22.74
- RCKT $3.33
- Average True Range (ATR)
- CVEO 0.57
- RCKT 0.28
- MACD
- CVEO -0.03
- RCKT 0.09
- Stochastic Oscillator
- CVEO 50.22
- RCKT 26.59
About CVEO Civeo Corporation (Canada)
Civeo Corp provides hospitality services to the natural resources industry in Canada, Australia and the United States. The company provides a full suite of services for guests, including lodging, catering and food service, housekeeping and maintenance at accommodation facilities that the company or its customers own. The company provides services that support the day-to-day operations of these facilities, such as laundry, facility management and maintenance, water and wastewater treatments, power generation, communication systems, security and logistics. The company operates in active oil, metallurgical coal, liquefied natural gas and iron ore-producing regions. The company operates in three reportable business segments Canada, Australia and the United States.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.